Full year 2025 financial guidance excludes any potential share repurchase or additional M&A activity. CEO Dr. Steve Cutler commented, "ICON continues to navigate dynamic clinical development ...
Full year 2025 financial guidance excludes ... to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should ...
Full year 2025 financial guidance excludes any potential share repurchase ... and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to ...
ICON has laid off a large number of its staff ... A dramatic reduction in force of this magnitude would not be undertaken lightly, and clearly there is a serious financial situation at play. Companies ...